Hosted on MSN31m
Eisai wins orphan drug status for Lenvima for esophageal cancerThe U.S. FDA has granted orphan drug designation to Eisai's (OTCPK:ESALF) Lenvima (lenvatinib) for esophageal cancer. The ...
During a Case-Based Roundtable® event, Matthew Campbell, MD, MS, moderated a discussion on treatment for a 61-year-old ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback